Company: ANIX
Filing Date: 2025-09-10
Form Type: S-3
Source: 0001493152-25-013010
Chunk: 0

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: S-3
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on September 10, 2025</div>

Registration No. 333-__________

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-3

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

Anixa Biosciences, Inc.

(Exact name of registrant as specified in its charter)</div>

| Delaware                 |     |                6794 |     | 11-2622630     |
| (State                   
 or other jurisdiction of |     |            (Primary 
 Standard Industrial |     | (I.R.S.        
 Employer       |
| incorporation            
 or organization)         |     |      Classification 
        Code Number) |     | Identification 
 Number)        |

<div align='center'>3150 Almaden Expressway, Suite 250

San Jose, CA 95118

(408) 708-9808

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Dr. Amit Kumar

Chairman and Chief Executive Officer

Anixa Biosciences, Inc.

3150 Almaden Expressway, Suite 250

San Jose, CA 95118

(408) 708-9808

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Please send a copy of all communications to:

Barry I. Grossman, Esq.

Matthew Bernstein, Esq.

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas

New York, New York 10105-0302

(212) 370-1300</div>

Approximate date of commencement proposed sale to the public: From time to time after the effective date of this Registration Statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities